Central Admixture Pharmacy Services Inc 2023-10-11 Health serious FDA
Health · FDA · Recall #FDA-D-0015-2024
fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 50… Recall
Issued October 11, 2023 · Central Admixture Pharmacy Services Inc
In October 2023, Central Admixture Pharmacy Services Inc recalled the fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 50…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of assurance of sterility:
What you should do
- 1 Stop using fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 50… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Central Admixture Pharmacy Services Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Central Admixture Pharmacy Services Inc
- Category
- Health
- Recall date
- October 11, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0015-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Central Admixture Pharmacy Services Inc has 43 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.